Effect of Immunosuppressant Blood Levels on Serum Concentration of Interleukin-17 and -23 in Stable Liver Transplant Recipients

Transplantation Proceedings

Volumn 41, Issue 3, 2009, Pages 1025-1027

  Fabrega E ^a   Lopez Hoyos M ^a   San Segundo, D ^a   Casafont, F ^a   Benito, M J ^a   Pons Romero, F ^a  

^a HOSPITAL UNIVERSITARIO MARQUÉS DE VALDECILLA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN; INTERLEUKIN 17; INTERLEUKIN 23; TACROLIMUS;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG BLOOD LEVEL; GRAFT RECIPIENT; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LIVER TRANSPLANTATION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL;

AGED; COHORT STUDIES; CYCLOSPORINE; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INTERLEUKIN-17; INTERLEUKIN-23; LIVER CIRRHOSIS, ALCOHOLIC; LIVER DISEASES; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; REFERENCE VALUES; TACROLIMUS; TH1 CELLS; TH2 CELLS;

EID: 64349091740     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2009.01.046     Document Type: Article

References (5)

1. Kolls J.K., and Lindén A. Interleukin-17 family members and inflammation. Immunity 21 (2004) 467
2. H-17 cells in the circle of immunity and autoimmunity. Nat Immunol 8 (2007) 345
3. Martinez-Llordella M., Lozano J.J., Puig-Rey I., et al. Using transcriptional profiling to develop a diagnostic test of operational tolerance in liver transplant recipients. J Clin Invest 118 (2008) 2845
4. San Segundo D., Fábrega E., López-Hoyos M., et al. Reduced numbers of blood natural regulatory T cells in stable liver transplant recipients with high levels of calcineurin inhibitors. Transplant Proc 39 (2007) 2290
5. Orlando G., Manzia T., Baiochi L., et al. The Tor Vergata weaning off immunosuppression protocol in stable HCV liver transplant patients: the updated follow up at 78 months. Transplant Immunol 20 (2008) 43